InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: A deleted message

Wednesday, 04/28/2021 1:54:42 AM

Wednesday, April 28, 2021 1:54:42 AM

Post# of 233221

lenzilumab was on my list , but I evaluated that leronlimab is a MUCH better drug


Have you looked at lenzilumab and CAR-T? Apparently, CAR-T has serious toxicity issues. Lenzilumab seems to eliminate those issues. They will be starting a phase II soon where they will test it with a bunch of different CAR-T therapies. Lenzilumab could be a game-changer by allowing CAR-T therapy to be practical.

https://www.targetedonc.com/view/lenzilumab-plus-axi-cel-achieves-responses-in-100-of-patients-with-dlbcl-with-limited-toxicity-in-small-study

https://www.biospace.com/article/humanigen-s-cytokine-storm-control-drug-positive-in-car-t-trial/?utm_source=socialmedia

https://www.healio.com/news/hematology-oncology/20210422/lenzilumab-before-cart-induces-high-response-rates-without-severe-toxicities
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News